This week, Glaukos’ investigational epi-on CXL therapy shows promise in phase 3 trials, a new dry eye drug shows an excellent safety profile and contacts infused with gold nanoparticles may help manage red-green color blindness. Source: AAO
This prospective study compared the performance of retinal specialists and artificial intelligence (AI) algorithm in detecting retinal fluid from spectral-domain OCT scans. Source: AAO
This retrospective, comparative, nonrandomized study assessed several approaches for managing patients with moderate to severe thyroid-associated orbitopathy. Source: AAO
Researchers characterized orbital roof fractures in adults who presented at a single level 1 tertiary care center between 2015 and 2018. Source: AAO
Researchers assessed whether the use of routine preoperative testing leads to delayed surgery and falls in Medicare beneficiaries awaiting cataract surgery. Source: AAO
This week, scientists discover new glaucoma-related genetic variants, the pandemic adds to the prevalence of myopia and Tennessee locals spot a deer with a rare case of corneal dermoids. Source: AAO
These studies examined cases of vision loss as the presenting sign or symptom of COVID-19. Source: AAO
These studies examined cases of vision loss after a diagnosis of COVID-19. Source: AAO
This IRIS Registry study investigated the rate of return to the operating room after vitrectomy for vitreous opacities. Source: AAO
In this population-based analysis, investigators evaluated ophthalmologic disorders associated with autism spectrum disorder. Source: AAO